Funding Opportunity
< search for funding opportunities
< search for funding opportunities
Research
2022 Early-stage investigator grant
Through our Early-Stage Investigator Grant Program, CCC hopes to accelerate the development of therapeutic treatments and disease-modifying advancements for those living with CHD2-related disorders. This grant program is designed to facilitate preliminary investigations that will potentially lay the groundwork for subsequent grants from the government, industry, or other funding sources, including Coalition to Cure CHD2.
CCC is interested in supporting research that advances the understanding of the cellular, molecular, genetic, and systems-level mechanisms of CHD2-related disorders. However, priority will be given to innovative projects which could potentially lead to therapeutic treatments or a cure for those with CHD2-related disorders.
CCC is interested in supporting research that advances the understanding of the cellular, molecular, genetic, and systems-level mechanisms of CHD2-related disorders. However, priority will be given to innovative projects which could potentially lead to therapeutic treatments or a cure for those with CHD2-related disorders.
Tags: CHD2, Mechanisms
Opportunity Contact:
Christine Salmi
Christine Salmi
LOI DatesOpen: 2/17/22
Close: 4/15/22
Response: 4/15/22
Application DatesOpen: 5/15/22
Close: 7/11/22
Response: 8/15/22
Funding Level: $30,000
Funding Length: 12 months
Funding Length: 12 months
Please enter your email address below. If you are already a member you will be logged in.
If you are not a current member, you will be registered automatically.
The email address you entered is associated with an existing account.